NKG2A Expression among CD8 Cells Is Associated with COVID-19 Progression in Hypertensive Patients: Insights from the

Renata Moll-Bernardes1, Sérgio C Fortier1,2, Andréa S Sousa1,3

  • 1D'Or Institute for Research and Education, Rio de Janeiro 22281-100, Brazil.

Insights

Hypertension patients with COVID-19 and higher CD8+ NKG2A MFI on admission faced severe disease progression. This immune marker, along with clinical factors, indicates a high risk, suggesting T cell exhaustion in severe cases.

Area of Science:

  • Immunology
  • Virology
  • Cardiology

Background:

  • Cardiovascular comorbidities and immune dysregulation are linked to severe COVID-19.
  • Hypertension is a significant risk factor for adverse COVID-19 outcomes.
  • Understanding immune cell profiles in hypertensive COVID-19 patients is crucial for predicting disease severity.

Purpose of the Study:

  • To investigate the immune cell profile in hospitalized hypertensive patients with COVID-19.
  • To identify immune cell subsets associated with progression to severe COVID-19.
  • To explore the relationship between immune markers and clinical variables in predicting disease severity.

Main Methods:

  • A logistic regression model was used to analyze data from 156 hospitalized hypertensive patients with COVID-19.
  • Clinical variables and immune cell subsets were assessed on admission.
  • The primary outcome was progression to severe COVID-19 disease.

Main Results:

  • Obesity, diabetes, low oxygen saturation, lung CT findings, elevated C-reactive protein, and altered lymphocyte counts (total, CD4+, CD8+, CD4/CD8 ratio) were associated with severe COVID-19.
  • Increased CD8+ NKG2A MFI (Mean Fluorescence Intensity) on admission was significantly linked to a higher risk of progression.
  • CD8+ HLA-DR MFI also showed association with disease progression.

Conclusions:

  • Increased CD8+ NKG2A MFI at hospital admission is a key indicator of severe COVID-19 progression risk in hypertensive patients.
  • Findings support the hypothesis of T cell exhaustion in severe COVID-19, evidenced by NKG2A expression.
  • These insights may offer potential therapeutic targets for mitigating severe acute respiratory syndrome coronavirus 2 infection.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
69
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
46
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
69
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.0K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.3K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
278